Summary
Boston Scientific Corporation (BSX) filed an 8-K report on October 30, 2014, detailing amendments and approvals related to executive compensation and retirement plans. The most significant updates concern the 2015 Annual Bonus Plan and two new Performance Share Programs (PSPs) for 2015, designed to align executive incentives with company performance and shareholder value. These plans introduce specific performance metrics and award structures, with provisions for recoupment in cases of misconduct or financial restatements. Additionally, the report includes an amendment and restatement of the Executive Retirement Plan, introducing a new eligibility classification for "Grandfathered Individuals" with specific criteria related to executive roles and "Special Assignments." These changes are effective in late 2014 and early 2015, signaling a focus on performance-driven compensation and executive retention strategies for the upcoming fiscal year.
Key Highlights
- 1Approval of the 2015 Annual Bonus Plan, with performance tied to adjusted EPS and global sales (constant currency).
- 2Introduction of the 2015 Total Shareholder Return Performance Share Program (TSR PSP) to align executive pay with stock performance relative to the S&P 500 Healthcare Index.
- 3Establishment of the 2015 Free Cash Flow Performance Share Program (FCF PSP) to incentivize achievement of key free cash flow objectives.
- 4Both 2015 PSPs are structured with award ranges (0-200% for TSR, 0-150% for FCF) and vesting requirements.
- 5Inclusion of recoupment policies (clawbacks) for both annual bonuses and performance shares in cases of executive misconduct, financial restatements, or legal requirements.
- 6Amendment and restatement of the Executive Retirement Plan, creating a new "Grandfathered Individual" eligibility for certain senior executives in "Special Assignments."
- 7Specific lump sum retirement benefit calculations for Grandfathered Individuals based on their tenure in executive roles and "Special Assignments."